Veracyte CAO has 1,361 shares withheld for tax

Veracyte’s chief accounting officer had shares withheld for RSU tax obligations, leaving 43,226 shares directly held.

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) reported that Jonathan Wygant, its VP and Chief Accounting Officer, had 1,361 shares of common stock withheld on September 2, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. This withholding is explicitly stated not to be a sale. After this transaction, he directly holds 43,226 shares, which include 514 shares purchased on July 31, 2026 under Veracyte’s Employee Stock Purchase Plan. No transactions are reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Tax Withholding: 1,361 shares

Tax Withholding 1 txn

Insider Wygant Jonathan

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	1,361	$44.88	$61K

Holdings After Transaction: Common Stock — 43,226 shares (Direct)

Footnotes (2)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
2. F2. Includes 514 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Key Figures

Shares withheld for taxes: 1,361 shares Reported value per share: $44.88 per share Shares held after transaction: 43,226 shares +1 more

4 metrics

Shares withheld for taxes 1,361 shares Withheld on September 2, 2026 to satisfy RSU tax withholding obligations

Reported value per share $44.88 per share Applied to 1,361 Veracyte common shares withheld for taxes

Shares held after transaction 43,226 shares Direct Veracyte common stock holdings following the September 2, 2026 withholding

ESPP shares included in holdings 514 shares Common shares purchased on July 31, 2026 under Veracyte’s Employee Stock Purchase Plan

Key Terms

restricted stock units, tax withholding obligations, Employee Stock Purchase Plan

3 terms

restricted stock units financial

"in connection with the vesting of certain restricted stock units on September 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations in connection"

Employee Stock Purchase Plan financial

"purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

What insider transaction did VCYT disclose for Jonathan Wygant on September 2, 2026?

Veracyte disclosed that Jonathan Wygant had 1,361 shares of common stock withheld for tax withholding obligations tied to RSU vesting on September 2, 2026. The company states this does not represent a sale of shares.

How many VERACYTE (VCYT) shares does Jonathan Wygant hold after this Form 4 event?

After the September 2, 2026 tax-withholding transaction, Jonathan Wygant directly holds 43,226 shares of Veracyte common stock. This balance includes 514 shares purchased on July 31, 2026 under the company’s Employee Stock Purchase Plan.

Was the VCYT insider transaction on September 2, 2026 a market sale?

No. The filing explains that the 1,361 shares were withheld to satisfy tax withholding obligations from RSU vesting and explicitly states that the event does not represent a sale of Veracyte stock on the open market.

What price per share is reported for the VCYT tax-withholding shares?

The Form 4 reports a value of $44.88 per share for the 1,361 Veracyte shares withheld to cover tax obligations in connection with the RSU vesting on September 2, 2026.

Were the VCYT insider transactions made under a Rule 10b5-1 plan?

No. The document-level checkbox indicates no Rule 10b5-1 trading plan for the reported transactions, and the footnotes do not describe any pre-arranged trading plan for this tax-withholding event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 07:54 PM Accepted by SEC EDGAR 09/04/2026 - 07:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wygant Jonathan

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		F(1)		1,361	D	$44.88	43,226(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.

2. Includes 514 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Remarks:

	/s/ Jonathan Wygant	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)